Protein Requirements Amongst Male Masters-Level Athletes Following a Cycling Exercise Bout as Determined by the Indicator Amino Acid Oxidation Technique
- Conditions
- Increased Metabolic RequirementsDietary Reference IntakesHealthy
- Interventions
- Dietary Supplement: Amino Acid Intake
- Registration Number
- NCT06431334
- Lead Sponsor
- McGill University
- Brief Summary
Masters level cyclists are a population above the age of 35 years who frequently participate in prolonged as well as heavy-volume training. Like most endurance-trained athletes, a greater recommended dietary allowance (RDA) for protein of 1.2-1.4 g/kg/bw is suggested.
Dietary protein intake is vital for maximizing the benefits of training and ensuring optimal recovery. Dietary recommendations traditionally have been determined through nitrogen balance techniques, however, recent research indicates how this method is potentially underestimating protein requirements. Therefore, there is a need to reassess current dietary recommendations in order to meet the demands of physical activity for highly active populations.
Recent efforts to understand protein requirements during rest and following exercise have been completed using the indicator amino acid technique (IAAO). This non-invasive method is reported to provide a robust measure of protein requirements. However, there is limited work in older (≥60 years) active populations.
The purpose of this study is to measure the protein requirements in master cyclists, following an endurance training session, using the non-invasive IAAO technique.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 8
- 18.5< BMI <35 kg/m^2
- Overtly healthy masters level cyclists ≥65 years
- Masters level cyclist training (>4 days per week; ~100 km per week)
- Body mass stable over previous 6-months
- Availability for multiple metabolic trials (~7 trials)
- Ability to travel to and from laboratory facility
- Recent history of weight loss or weight gain (>5% body weight)
- Uncontrolled hypertension
- ≥2 chronic diseases (e.g. diabetes, osteoporosis, dyslipidemia)
- Acute illness that could affect protein metabolism (HIV, renal dysfunction, influenza)
- Currently using anti-inflammatory medications
- Inability to adhere to study protocol (i.e., alcohol, caffeine, dietary restrictions)
- Regular tobacco user
- Illicit drug use
- Habitually ingesting ≥3 g/kg/bw
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Masters Level Cyclists Amino Acid Intake Participants are to be randomly assigned varying levels of amino acid intakes ranging between 0.5 to 2.8 g/kg/d
- Primary Outcome Measures
Name Time Method 13CO2 Excretion 7-weeks Measured by continuous-flow isotope ratio mass spectrometry
- Secondary Outcome Measures
Name Time Method L[13C]phenylalanine Oxidation 7-weeks Measured by gas chromatography-mass spectrometry
Trial Locations
- Locations (1)
McGill University
🇨🇦Montréal, Quebec, Canada